Shangri-La Farms proposes 50,000-plant cannabis facility in Delaware
The Smyrna cultivation proposal would become one of the largest licensed cannabis operations on the U.S. East Coast.

A modern greenhouse with an arched roof design under a clear blue sky in daylight.
Facility Scale and Regional Context
The proposed 50,000-plant canopy would position Shangri-La Farms as one of the three largest cultivation licensees in Delaware's adult-use program. For comparison, Pennsylvania caps cultivation licenses at 150,000 square feet of canopy; New Jersey's largest vertically integrated operators run facilities in the 40,000–60,000 plant range. Delaware's Division of Cannabis Control doesn't publish aggregate canopy data, but industry filings reviewed by CannIntel show the state's current largest cultivator operates approximately 35,000 plants across two sites.
Kent County hosts the Smyrna location. The county has emerged as Delaware's primary cultivation corridor since the state legalized adult-use sales in April 2023. Zoning ordinances there permit large-scale agricultural operations in designated rural zones, a regulatory advantage that's drawn five of the state's nine licensed cultivators to the region.
Shangri-La Farms hasn't disclosed the physical footprint of the proposed facility. At typical East Coast cultivation densities, a 50,000-plant operation would require 80,000–100,000 square feet of canopy space across flowering, vegetation, and mother rooms.
Delaware's Cultivation License Structure
Delaware operates a hybrid medical-adult-use framework that issues cultivation licenses without plant-count caps but imposes strict operational and security requirements. The state's enabling statute, House Bill 1, passed in April 2023, directed the Division of Cannabis Control to prioritize applications from Delaware residents and entities with demonstrated agricultural or horticultural experience. Shangri-La Farms' ownership structure hasn't been publicly disclosed in available filings.
Delaware issued its first wave of adult-use cultivation licenses in June 2023. As of August 2026, nine cultivation licenses are active. They support a retail network of 23 dispensaries statewide. The state doesn't enforce vertical integration; cultivators may wholesale to any licensed retailer or processor.
License applicants must demonstrate compliance with Delaware's Track-and-Trace system, which uses METRC for seed-to-sale inventory management. Facilities exceeding 10,000 plants face additional security audits, including perimeter fencing, 24-hour video surveillance with 90-day retention, and on-site security personnel during business hours.
Market Dynamics and Wholesale Pricing
Delaware's wholesale cannabis market has experienced price compression consistent with mature East Coast programs, with bulk flower prices declining from $2,400 per pound in Q2 2024 to approximately $1,800 per pound in Q2 2026. The state's retail market generated $147 million in adult-use sales in 2025, according to Division of Cannabis Control data, with per-capita consumption tracking slightly below New Jersey but above Maryland.
Large-scale cultivators in Delaware face the same federal tax burden as operators nationwide. Section 280E of the Internal Revenue Code disallows deductions for business expenses related to trafficking in Schedule I substances, leaving cultivators unable to deduct costs beyond cost of goods sold. Effective tax rates for profitable cultivators typically range from 40% to 70% of gross profit.
Scale players dominate the East Coast cultivation landscape. New Jersey's Curaleaf operates a 60,000-plant facility in Winslow; Pennsylvania's Trulieve runs a 120,000-square-foot grow in Brookville. Delaware's smaller market size has historically limited the economic case for facilities above 30,000 plants, but proximity to Pennsylvania and Maryland wholesale markets may alter that calculus if interstate commerce provisions advance under federal rescheduling.
Regulatory Timeline and Approval Process
Delaware's Division of Cannabis Control operates a 90-day review period for cultivation license applications, with extensions permitted for additional due diligence or public comment. Shangri-La Farms' application entered the queue in mid-August 2026; a preliminary determination is expected by November 2026. The Division hasn't published a formal approval rate, but industry sources say approximately 60% of cultivation applications filed since 2023 have received provisional licenses.
Kent County zoning approval is a parallel requirement. Smyrna's Planning and Zoning Commission must issue a special-use permit for cannabis cultivation in agricultural zones. The Commission typically schedules public hearings 30 days after application receipt. No public hearing date has been announced for the Shangri-La Farms proposal as of this reporting.
If approved, construction and commissioning of a 50,000-plant facility typically requires 12–18 months. Operators must pass a final Division inspection and demonstrate full METRC integration before receiving a certificate of operation.
Comparative Regulatory Frameworks
Delaware's approach contrasts sharply with plant-count caps in neighboring states and European medical programs. Maryland limits cultivation licenses to 250,000 square feet of canopy but doesn't specify plant counts; Pennsylvania's 150,000-square-foot cap translates to roughly 50,000–60,000 plants depending on cultivation method. Germany's BfArM, which oversees the country's medical cannabis supply chain, licenses cultivators under strict GMP standards with production quotas set annually by the Federal Institute for Drugs and Medical Devices. Canada's Health Canada doesn't impose plant-count limits but requires cultivators to forecast production volumes in license applications.
Delaware's lack of a hard cap mirrors Oregon's early adult-use framework, which resulted in significant oversupply and wholesale price collapse between 2017 and 2020. Oregon eventually imposed a temporary moratorium on new cultivation licenses. Delaware regulators have said they monitor aggregate canopy data to avoid Oregon-style oversupply, but no formal cap has been codified in statute.
What Comes Next
Three variables will determine whether Shangri-La Farms' proposal advances: Division of Cannabis Control approval, Kent County zoning clearance, and the operator's ability to demonstrate financial capacity for an 80,000-plus-square-foot buildout. Delaware's cultivation pipeline has slowed since the initial 2023 licensing wave. Only two new cultivation licenses have been issued in 2026 to date.
We'll be watching for the Division's preliminary determination, expected by late November 2026. If approved, Shangri-La Farms would likely begin operations in mid-2028. For full background on Delaware's cultivation sector, see the CannIntel topic hub on Delaware cannabis cultivation.
Frequently asked questions
How large is a 50,000-plant cannabis cultivation facility?
A 50,000-plant operation typically requires 80,000–100,000 square feet of canopy space, depending on cultivation method. This scale ranks among the largest licensed facilities in East Coast adult-use states, comparable to top-tier operations in New Jersey and Pennsylvania.
Does Delaware impose plant-count limits on cannabis cultivators?
No. Delaware's adult-use statute doesn't cap plant counts, unlike Pennsylvania's 150,000-square-foot limit or Maryland's 250,000-square-foot cap. Delaware regulators monitor aggregate canopy data but haven't codified a hard limit in statute.
What is the approval timeline for Delaware cultivation licenses?
The Division of Cannabis Control operates a 90-day review period for cultivation applications, with extensions permitted for additional due diligence. Applicants must also secure Kent County zoning approval, which typically adds 30–60 days for public hearing and commission review.
What are current wholesale cannabis prices in Delaware?
Delaware wholesale flower prices averaged approximately $1,800 per pound in Q2 2026, down from $2,400 per pound in Q2 2024. Price compression reflects increased cultivation capacity and competition consistent with mature East Coast markets.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Canopy Growth Secures EU-GMP Certification at Smiths Falls
Canopy Growth's Smiths Falls site is now certified for softgel manufacturing and primary packaging of softgels, oral liquids and dried flower, extending its EU-GMP supply chain.

INFARMED Approves Tilray Medical's In-House EU-GMP Testing in Portugal
Portugal's medicines regulator cleared Tilray Medical to run quality-control testing at its own Portuguese site, a step aimed at speeding product releases into regulated markets.

Business of Cannabis Maps 2026 Cannabis Stocks and How They Trade
A new 2026 guide sorts listed cannabis companies by exchange and trading behavior, and the split still follows federal law.
More from the newsroom

County Commissioners Vote for Cannabis Moratorium, Herald Reports
A county board voted to pause new cannabis operations, the Austin Daily Herald reported, adding to Minnesota's patchwork of local rules under the 2023 adult-use law.

Ex-DEA Official Warns Against Schedule III Licenses Before Court Rules
A former senior DEA official urged that Schedule III marijuana licenses wait for a federal appeals court ruling, raising a sequencing question for operators and investors.

South Dakota AG Says Rescheduling Has 'Negligible Impact' on Medical Program
South Dakota's attorney general says a federal Schedule III move barely touches the state's voter-approved medical marijuana program, leaving 280E relief as the main operator-level change.